Drug intelligence / Profile preview

Fuke Qianjin

Development stage
Unknown
Lead developer
Zhuzhou Qianjin Pharmaceutical
Administration
Oral
01

Overview

Fuke Qianjin is a traditional Chinese medicine available in both tablet and capsule forms, approved by China's National Medical Products Administration. It is primarily used to treat gynecological inflammatory conditions including pelvic inflammatory disease (PID), chronic cervicitis, endometritis, and chronic pelvic inflammatory disease. The medication works by clearing heat and dampness, replenishing qi, and eliminating blood stasis. Clinical studies have shown that Fuke Qianjin has bacteriostatic and anti-inflammatory effects, and when combined with conventional antibiotics, it demonstrates improved clinical efficacy in treating various gynecological conditions. It has been shown to shorten the remission time of clinical symptoms, reduce serum inflammatory factors, improve endometrial thickness, normalize menstruation, and reduce relapse rates.

Brand names
Fuke Qianjin
Other names
FUKEFKQJDaughter of Department of Gynaecology
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Fuke Qianjin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuke Qianjin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call